Published in Panminerva Med on November 13, 1992
Effects on Liver Cirrhotic Patients' by a Nurse-led Clinic | NCT02957253
Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. J Clin Biochem Nutr (2007) 0.80
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev (2016) 0.76
Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community. J Mov Disord (2015) 0.75
Labile exocyclic amine protection of nucleosides in DNA, RNA and oligonucleotide analog synthesis facilitating N-deacylation, minimizing depurination and chain degradation. Biochimie (1993) 2.34
Absent innervation of skin and sweat glands in congenital insensitivity to pain with anhidrosis. Clin Neurophysiol (2000) 1.30
Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol (1997) 0.92
Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep (2000) 0.90
The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial. Rheumatol Int (2010) 0.88
Surface EMG alterations induced by underwater recording. J Electromyogr Kinesiol (2004) 0.88
Is atrial natriuretic peptide important in the circadian rhythm of arterial blood pressure? Am J Cardiol (1989) 0.87
Circadian rhythm of serum erythropoietin in healthy subjects. Riv Eur Sci Med Farmacol (1997) 0.87
Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation. Diabetologia (2012) 0.86
Imaging of spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 0.85
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis (2001) 0.84
[Work activities and the risk of multiple myeloma. A case-control study]. Med Lav (1991) 0.84
Occupational risk for hematological malignancies. Am J Hematol (1991) 0.84
Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation. J Card Fail (1997) 0.82
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes (2001) 0.82
No influence of aging on the circadian rhythm of erythropoietin in healthy subjects. Gerontology (1997) 0.82
[Socioeconomic status and survival in multiple myeloma]. Minerva Med (1990) 0.82
Analgesic effects of topical ketamine. Minerva Anestesiol (2014) 0.81
Circadian pattern of circulating plasma ACTH, cortisol, and aldosterone in patients with beta-thalassemia. Acta Endocrinol (Copenh) (1990) 0.81
Pain in fibromyalgia and related conditions. Reumatismo (2014) 0.81
Plasma cell leukemia. A report on 11 patients and review of the literature. Panminerva Med (1996) 0.81
The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases. Acta Haematol (1997) 0.81
Causes of hospitalisation before and after the 2009 L'Aquila earthquake. Intern Med J (2013) 0.80
Multiple myeloma: relationship between survival and cellular morphology. Am J Hematol (1990) 0.80
[The chronobiology of sudden cardiac death. The evidence for a circadian, circaseptimanal and circannual periodicity in its incidence]. Minerva Med (1990) 0.80
Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Biomed Pharmacother (1997) 0.80
The effects of parachlorophenylalanine and naloxone on acupuncture and electroacupuncture modulation of capsaicin-induced neurogenic edema in the rat hind paw. A controlled blind study. Clin Exp Rheumatol (2000) 0.79
Early development of EMG localized muscle fatigue in hand muscles of patients with chronic heart failure. Arch Phys Med Rehabil (1998) 0.79
[Simultaneous presentation of multiple myeloma and acute myelomonocytic leukemia in the absence of previous chemotherapy. Description of a case and review of the literature]. Minerva Med (1990) 0.79
Fibromyalgia syndrome: definition and diagnostic aspects. Reumatismo (2008) 0.79
Prognostic factors in multiple myeloma: a new staging system based on clinical and morphological features. Eur J Cancer (1991) 0.79
[Fatal pulmonary thromboembolism. A study of 178 cases]. Minerva Cardioangiol (1990) 0.78
Circadian distribution in fatal pulmonary thromboembolism. Am J Cardiol (1989) 0.78
Circadian rhythms of fibrinogen antithrombin III and plasminogen in chronic liver diseases of increasing severity. Haemostasis (1997) 0.78
Circadian rhythm of serum erythropoietin in myelodysplastic syndromes. Eur Rev Med Pharmacol Sci (2001) 0.78
Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED. BMC Surg (2012) 0.78
Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo (2008) 0.78
Circadian rhythms of plasma atriopeptin, plasma renin activity and plasma aldosterone in patients with hepatorenal syndrome. Life Sci (1997) 0.78
A possible role of atrial natriuretic peptide in ethanol-induced acute diuresis. Life Sci (1991) 0.78
Risk of monoclonal gammopathy of undetermined significance: a case-referent study. Am J Hematol (1996) 0.77
Circadian rhythm of arginine vasopressin in hepatorenal syndrome. Nephron (1998) 0.77
Circadian rhythm of serum erythropoietin in multiple myeloma. Am J Hematol (1996) 0.77
[Serum levels of magnesium in hepatic cirrhosis]. Quad Sclavo Diagn (1987) 0.77
Rheumatologic aspects of mineral water. Clin Dermatol (1997) 0.77
Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model. Biomed Pharmacother (1996) 0.77
Surface EMG signal alterations in Carpal Tunnel syndrome: a pilot study. Eur J Appl Physiol (2008) 0.77
[Fatal pulmonary thromboembolism: is its incidence increasing or diminishing? Analysis of 178 cases from 1971 to 1988]. Cardiologia (1989) 0.77
Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial. Curr Med Res Opin (1989) 0.77
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am (1996) 0.77
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. Clin Exp Rheumatol (1997) 0.77
Early detection of median nerve syndrome at the carpal tunnel with high-resolution 18 MHz ultrasonography in systemic sclerosis patients. Clin Exp Rheumatol (2010) 0.77
The evaluation of the fibromyalgia patients. Reumatismo (2008) 0.76
[Assessment of gallbladder motility in patients with alcoholic hepatic cirrhosis after a fatty meal. A real-time ultrasonography study]. Minerva Gastroenterol Dietol (1992) 0.76
Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid. Hepatology (1987) 0.76
[Diagnostic value of gamma glutamyl transpeptidase and the mean corpuscular volume in chronic hepatitis of alcoholic etiology]. Minerva Med (1995) 0.76
[Chrono-risks in the episodes of fatal pulmonary thromboembolism]. G Clin Med (1990) 0.76
Circadian rhythm of pituitary-adrenal axis in thalassemia. Recenti Prog Med (1990) 0.76
Pain in rheumatoid arthritis: a critical review. Reumatismo (2014) 0.76
Epidemiological chronorisk of stroke. Acta Neurol Scand (1990) 0.76
[Circadian rhythm of human lymphocyte subpopulations]. Quad Sclavo Diagn (1989) 0.76
Is sympathetic neural hyperactivity in chronic heart failure affected by heart transplantation? Eur Heart J (1993) 0.75
Isolated atrial myocardial infarction: pathological and clinical features in 10 cases. Cardiologia (1991) 0.75
Psycho-motor skills in hemiplegic patients: reaction time differences related to hemispheric lesion side. Neurophysiol Clin (1990) 0.75
Relationship between serum beta 2-microglobulin levels and total body tumour mass at diagnosis in myeloma. Br J Haematol (1991) 0.75
[Epidemiological study of chronic obstructive bronchopneumopathy in cement workers]. Arch Monaldi (1982) 0.75
The 'beta 2-microglobulin index' in the prognostic evaluation of multiple myeloma. Br J Haematol (1991) 0.75
[Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma]. Minerva Med (1990) 0.75
[Coenzyme A in chronic hepatopathies]. Clin Ter (1979) 0.75
[Epidemiologic chronorisk of acute cardio-cerebrovascular diseases]. Recenti Prog Med (1991) 0.75
Treatment of type C chronic active hepatitis with interferon-alpha 2a. Treatment duration does not influence biochemical remission but does decrease the relapse rate. J Clin Gastroenterol (1994) 0.75
Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency. Int J Clin Pharmacol Res (1990) 0.75
[Multiple myeloma: epidemiologic and clinical considerations]. G Ital Oncol (1991) 0.75
[Differentiated circadian chrono-risk of acute myocardial infarct]. Cardiologia (1990) 0.75
Seasonal periodicity in fatal pulmonary thromboembolism. Lancet (1990) 0.75
Multiple myeloma in L'Aquila and Avezzano, Italy, 1970-89. Changes in incidence rates, symptoms at diagnosis, and survival. Panminerva Med (1991) 0.75
Diurnal variations of serum beta 2-microglobulin in multiple myeloma. Life Sci (1991) 0.75
[Prognostic evaluation in multiple myeloma. Relationship between immunological types, single prognostic factors, clinical staging systems, morphological classification systems and survival]. Ann Ital Med Int (1991) 0.75
Paraprotein index: a simple prognostic parameter for multiple myeloma. Am J Hematol (1991) 0.75
[A case of Mobitz type II atrioventricular block diagnosed in uterus]. Cardiol Prat (1979) 0.75
Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension. J Clin Pharmacol (1991) 0.75